Levonorgestrel intrauterine system and breast cancer risk: An updated systematic review and meta-analysis of observational studies.

doi:10.1016/j.heliyon.2023.e14733

Levonorgestrel intrauterine system and breast cancer risk: An updated systematic review and meta-analysis of observational studies.

2023 · doi:10.1016/j.heliyon.2023.e14733 · PMID:37089342 · PMC10119507

OA: closed ⤵ 1 in-corpus citation

📄 Open PDF View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

This systematic review and meta-analysis of observational studies examined the relationship between the levonorgestrel intrauterine system and breast cancer risk.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Hormonal Contraception and the Risk of Breast Cancer in Women of Reproductive Age: A Meta-Analysis. 2023

Cited by (1)

Hormonal Contraception and the Risk of Breast Cancer in Women of Reproductive Age: A Meta-Analysis. 2023

Source provenance

europepmc: last seen: 2026-06-21T06:12:49.409960+00:00